Imricor Medical Systems

Imricor Medical Systems is a US-based medical device manufacturer specializing in MRI-compatible ablation and diagnostic catheters for interventional cardiac magnetic resonance (iCMR) procedures. Founded in 2006 and headquartered in Burnsville, Minnesota, the company pioneered safe MRI-guided cardiac catheter ablation technology. The company's flagship product, the Vision-MR Ablation Catheter 2.0, operates under real-time MRI guidance to treat cardiac arrhythmias, particularly ventricular tachycardia, with improved safety and efficiency compared to traditional X-ray fluoroscopy methods. Imricor's product portfolio also includes the Vision-MR Diagnostic Catheter, Advantage-MR EP Recorder/Stimulator for electrophysiology recording and cardiac stimulation, and the NorthStar Mapping System for cardiac substrate visualization and ablation guidance within the MRI environment. The company holds CE Mark approval in Europe and has recently obtained FDA clearance in the United States. Imricor serves approximately 15 European sites and has established partnerships including a sales agreement with Philips for broader market distribution.